Skip to main content
. 2020 Oct 8;12:553635. doi: 10.3389/fnagi.2020.553635

FIGURE 2.

FIGURE 2

Overview of the pipeline to ascertaining biologically suitable subpopulations for drug repurposing. GWAS, genome-wide association study; WGCNA, weighted correlation network analysis; DE, differential expression analysis; DMP, differential methylation probe; DMR, differential methylation region; DMB, differential methylation block; PCA, principal component analysis; PLS-DA, partial least squares discrimination analysis; OUTs, operational taxonomic unit.